<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >Hypertension or 'high blood pressure' carries an increased risk of early death&nbsp;from&nbsp;stroke, heart&nbsp;attack,&nbsp;heart&nbsp;failure&nbsp;and&nbsp;kidney&nbsp;failure if&nbsp;it&nbsp;is not detected early and properly controlled. Owing to this, the focus&nbsp;must be on when to initiate treatment, rather than how hypertension should be defined.</span></p><p style="text-align:justify;"><span >Since there are often no specific symptoms associated with hypertension, there is the need for regular blood pressure (BP) screening in the adult population for early detection.</span></p><p style="text-align:justify;"><span >In the general adult population, treatment must be initiated at a&nbsp; BP of 140/90 mmHg or higher for individuals below 60 years of age, and 150/90 mmHg or higher in those above 60 years. For individuals with diabetes mellitus or non-diabetics with Chronic Kidney Disease (CKD), treatment for hypertension must be initiated at a BP of 140/90 mmHg, irrespective of&nbsp;age.</span></p><p style="text-align:justify;"><span >In the majority of patients with hypertension, no specific underlying cause&nbsp;is&nbsp;identified&nbsp;(primary hypertension).&nbsp;In&nbsp;these&nbsp;individuals,&nbsp;increasing age, family history,&nbsp;excess body weight, lack of physical activity and excessive alcohol intake may be possible predisposing factors. In about 10%&nbsp;of&nbsp;cases&nbsp;of&nbsp;hypertension,&nbsp;there may&nbsp;be&nbsp;an&nbsp;underlying&nbsp;kidney disease, endocrine disorder,&nbsp;renal artery stenosis or coarctation of the aorta (secondary&nbsp;hypertension).</span></p><p style="text-align:justify;"><span >Once a diagnosis of hypertension is made, the individual should&nbsp; &nbsp; &nbsp;be evaluated to exclude secondary causes and to identify other existing cardiovascular risk factors e.g. diabetes, dyslipidaemia, hyperuricaemia, etc.</span></p><p style="text-align:justify;">&nbsp;</p><h3>CAUSES</h3><p>•&nbsp; Primary&nbsp;hypertension</p><p>•&nbsp; Secondary&nbsp;hypertension</p><p>•  Kidney&nbsp;related-CKD,&nbsp;polycystic&nbsp;kidney&nbsp;disease</p><p>•  Endocrine - phaeochromocytoma, Cushing's syndrome, Conn's&nbsp;syndrome,&nbsp;hypothyroidism,&nbsp;hyperthyroidism,&nbsp;acromegaly</p><p>• &nbsp; &nbsp; Vascular - renal artery stenosis, coarctation of the aorta</p><h3>SYMPTOMS</h3><p>•&nbsp; Usually&nbsp;none</p><p>•&nbsp; Occasionally,</p><p>•  Headaches</p><p>•  Palpitations</p><p>•  Dizziness</p><p>•  Easy&nbsp;fatiguability</p><h3>SIGNS</h3><p>•&nbsp; Blood pressure&nbsp;2"&nbsp;140/90&nbsp;mmHg</p><p>•&nbsp; Displaced apex&nbsp;beat</p><p>•&nbsp; Signs&nbsp;pointing to&nbsp;a&nbsp;specific&nbsp;cause&nbsp;for&nbsp;secondary&nbsp;hypertension</p><h3>INVESTIGATIONS</h3><p>•&nbsp; FBC</p><p>•&nbsp; Urinalysis</p><p>•&nbsp; Blood urea, electrolytes and&nbsp;creatinine</p><p>•&nbsp; Blood&nbsp;glucose</p><p>•&nbsp; Serum&nbsp;lipids</p><p>•&nbsp; Serum uric&nbsp;acid</p><p>•&nbsp; Chest&nbsp;X-ray</p><p>•&nbsp; 12-lead&nbsp;ECG</p><p>•&nbsp; Ultrasound scan of kidneys and adrenals (in suspected secondary hypertension)</p><p>•&nbsp; Echocardiogram</p><h3>TREATMENT</h3><p><strong>Treatment objectives</strong></p><p>•&nbsp; To&nbsp;reduce blood pressure levels to recommended&nbsp;targets:</p><p>•  &lt;&nbsp;140/90mmHg&nbsp;for&nbsp;age&nbsp;below&nbsp;60&nbsp;years,&nbsp;diabetes, CKD</p><p>•  &lt; 150/90 mmHg for age above 60&nbsp;years</p><p>•&nbsp; To&nbsp;manage&nbsp;co-morbid conditions&nbsp;e.g.&nbsp;obesity,&nbsp;diabetes,&nbsp;lipids&nbsp;etc.</p><p>•&nbsp; To&nbsp;prevent&nbsp;cardiovascular,&nbsp;cerebrovascular&nbsp;and&nbsp;renal complications</p><p>•&nbsp; To&nbsp;promote therapeutic lifestyle changes e.g. smoking cessation, regular&nbsp;physical&nbsp;activity,&nbsp;reduction&nbsp;in&nbsp;alchohol intake</p><p>•&nbsp; To&nbsp;identify and manage secondary hypertension&nbsp;appropriately</p><h3>Non-pharmacological treatment</h3><p>•&nbsp; Reduce salt&nbsp;intake</p><p>•&nbsp; Reduce animal fat&nbsp;intake</p><p>•&nbsp; Ensure regular fruit and vegetable&nbsp;intake</p><p>•&nbsp; Weight reduction in obese and overweight&nbsp;individuals</p><p>•&nbsp; Regular&nbsp;exercise e.g.&nbsp;brisk&nbsp;walking for&nbsp;30&nbsp;minutes&nbsp;3&nbsp;times&nbsp;a&nbsp;week</p><p>•&nbsp; Reduction in alcohol&nbsp;consumption</p><p>•&nbsp; Avoid or quit&nbsp;smoking</p><p>&nbsp;</p><h3>Pharmacological treatment</h3><p><span ><strong>A. Treatment of&nbsp;hypertension&nbsp;</strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment</strong></span></p><p><span ><strong>&nbsp;Evidence Rating:&nbsp;[A]</strong></span></p><h3>Thiazide Diuretics:</h3><p>•&nbsp; Bendroflumethiazide, oral, 2.5 mg&nbsp;daily</p><h3>Or</h3><p>•&nbsp; Hydrochlorothiazide, oral, 12.5 mg-25 mg&nbsp;daily</p><h3>And/Or</h3><h3>Calcium Channel Blockers:</h3><ul><li>Amlodipine,&nbsp;oral,&nbsp;5-10&nbsp;mg&nbsp;daily</li></ul><h3>Or</h3><p>•&nbsp; Nifedipine retard, oral, 10-40 mg 12&nbsp;hourly</p><h3>And/Or</h3><p><strong>Angiotensin-converting enzyme (ACE) inhibitors</strong></p><p>•&nbsp; Lisinopril, oral, 5-40 mg&nbsp;daily</p><h3>Or</h3><p>•&nbsp; Ramipril, oral, 2.5-10 mg&nbsp;daily</p><h3>Or</h3><h3><strong>Angiotensin receptor&nbsp;blockers</strong></h3><ul><li>Losartan, oral, 25-100 mg&nbsp;daily</li></ul><h3>Or</h3><p>&nbsp; &nbsp; &nbsp;• Candesartan, oral, 4-32 mg&nbsp;daily</p><h3>Or</h3><ul><li>Valsartan, oral, 80-160 mg&nbsp;daily</li></ul><h3>And/Or</h3><p><strong>Beta-blockers:</strong></p><p>•&nbsp; Atenolol, oral, 50 -100 mg&nbsp;daily</p><h3>Or</h3><p>•&nbsp; Bisoprolol, oral, 5-20 mg&nbsp;daily</p><h3>Or</h3><p>•&nbsp; Metoprolol, oral, 50-200 mg 12&nbsp;hourly</p><h3>Or</h3><ul><li>Carvedilol, oral, 12.5-50 mg&nbsp;daily</li></ul><h3>Or</h3><p>•&nbsp; Labetalol, oral, 100-400 mg 12&nbsp;hourly</p><p><span ><strong>2<sup>nd</sup> Line Treatment&nbsp;</strong></span></p><p><span ><strong>Evidence Rating: [C]&nbsp;</strong></span></p><p><strong>Centrally acting agents</strong></p><p>•&nbsp; Methyldopa, oral, 250 mg-1g 8-12&nbsp;hourly</p><h3>And/Or</h3><p><strong>Vasodilators</strong></p><p>•&nbsp; Hydralazine, oral, 25-50 mg 12&nbsp;hourly</p><h3>And/Or</h3><p><strong>Alpha-blockers</strong></p><p>•&nbsp; Prazosin,&nbsp;oral,&nbsp;0.5&nbsp;mg&nbsp;8-12hourly&nbsp;and&nbsp;increasing&nbsp;gradually&nbsp;to&nbsp;a&nbsp;max. dose of 20&nbsp;mg</p><h3>And/Or</h3><p><strong>Aldosterone antagonists</strong></p><p>• Spironolactone, oral, 25-50 mg&nbsp;daily</p><p>&nbsp;</p><h3>REFERRAL CRITERIA</h3><p><span >Refer the following categories of hypertensive patients to an</span></p><p><span >appropriate specialist:</span></p><p>•&nbsp; Those&nbsp;not&nbsp;achieving&nbsp;the&nbsp;target&nbsp;blood pressure&nbsp;(BP)&nbsp;level after&nbsp;several months of&nbsp;treatment</p><p>•&nbsp; Those&nbsp;on&nbsp;three&nbsp;or&nbsp;more&nbsp;anti-hypertensive&nbsp;drugs,&nbsp;yet&nbsp;have&nbsp;poor&nbsp;BP</p><p>control</p><p>•&nbsp; Those&nbsp;with&nbsp;worsening&nbsp;of&nbsp;BP&nbsp;over&nbsp;a&nbsp;few&nbsp;weeks&nbsp;or&nbsp;months</p><p>•&nbsp; Those&nbsp;with&nbsp;plasma&nbsp;creatinine&nbsp;levels&nbsp;above&nbsp;the&nbsp;upper&nbsp;limit&nbsp;of&nbsp;normal</p><p>•&nbsp; Those with diabetes&nbsp;mellitus</p><p>•&nbsp; Those with multiple risk factors (diabetes, dyslipidaemia, obesity,&nbsp;family history of heart&nbsp;disease)</p><p>•&nbsp; Those not on diuretics but have persistently low potassium&nbsp;on</p><p>repeated blood tests</p><p>•&nbsp; All&nbsp;children, young&nbsp;adults&nbsp;and&nbsp;pregnant&nbsp;women&nbsp;with&nbsp;elevated BP</p>
</body>
</html>
